MTOR and neoplasm: The combination of an mTOR and autophagy inhibitor may be important for clinical efficacy, as a study in prostate tumour xenograft models found that the combination of the mTOR inhibitor AZD5363 and chloroquine significantly reduced tumour volume, while either drug alone did not [80].